BACKGROUND: Abandonment of paediatric cancer treatment is a common problem in developing countries. Little is known about the guardians' perspective on cancer treatment in these countries, especially the factors that affect adherence. METHODS: Following a pilot study enquiring into the possible causes of abandonment, a problem analysis diagram was drawn which helped to develop the questionnaires. Semi-structured interviews (n = 83) and focus group discussions (n = 8) were held with the guardians of 25 Burkitt lymphoma patients and 7 Wilms tumour patients at different phases of therapy in Malawi. RESULTS: Parents in Malawi are very motivated to continue treatment if they think that it will cure their child. Financial costs are important concerns. Not all tasks at home are assumed by other household members. The diagnosis of cancer was unknown before being told about it in hospital and caused fear of recurrence and death. Guardians are reluctant to ask the health personnel questions. They worry that taking frequent blood samples will weaken their child. The side effects of the chemotherapy are seen as a proof of efficacy. CONCLUSION: It is important to appreciate the guardians' concerns when offering treatment that requires their sustained commitment. It is necessary to provide not only medical treatment, but also travel allowances and adequate nutritional support during long hospital stays to impoverished families. Information should be given proactively. (c) 2008 Wiley-Liss, Inc.
BACKGROUND: Abandonment of paediatric cancer treatment is a common problem in developing countries. Little is known about the guardians' perspective on cancer treatment in these countries, especially the factors that affect adherence. METHODS: Following a pilot study enquiring into the possible causes of abandonment, a problem analysis diagram was drawn which helped to develop the questionnaires. Semi-structured interviews (n = 83) and focus group discussions (n = 8) were held with the guardians of 25 Burkitt lymphomapatients and 7 Wilms tumourpatients at different phases of therapy in Malawi. RESULTS: Parents in Malawi are very motivated to continue treatment if they think that it will cure their child. Financial costs are important concerns. Not all tasks at home are assumed by other household members. The diagnosis of cancer was unknown before being told about it in hospital and caused fear of recurrence and death. Guardians are reluctant to ask the health personnel questions. They worry that taking frequent blood samples will weaken their child. The side effects of the chemotherapy are seen as a proof of efficacy. CONCLUSION: It is important to appreciate the guardians' concerns when offering treatment that requires their sustained commitment. It is necessary to provide not only medical treatment, but also travel allowances and adequate nutritional support during long hospital stays to impoverished families. Information should be given proactively. (c) 2008 Wiley-Liss, Inc.
Authors: Carmen Salaverria; Nuria Rossell; Angelica Hernandez; Soad Fuentes Alabi; Roberto Vasquez; Miguel Bonilla; Catherine G Lam; Raul C Ribeiro Journal: Pediatr Blood Cancer Date: 2015-04-29 Impact factor: 3.167
Authors: Jaime Libes; Oliver Oruko; Fatmah Abdallah; Jessie Githanga; James Ndung'u; Joyce Musimbi; Festus Njuguna; Kirtika Patel; John White; Jason R Axt; James A O'Neill; Martha Shrubsole; Ming Li; Harold N Lovvorn Journal: Pediatr Blood Cancer Date: 2014-11-08 Impact factor: 3.167
Authors: Trijn Israëls; Joyce Kambugu; Francine Kouya; Nader Kim El-Mallawany; Peter B Hesseling; Gertjan J L Kaspers; Tim Eden; Lorna Renner; Elizabeth M Molyneux Journal: Nat Rev Clin Oncol Date: 2013-07-30 Impact factor: 66.675
Authors: Christopher C Stanley; Toon van der Gronde; Kate D Westmoreland; Ande Salima; Amy Amuquandoh; Salama Itimu; Agness Manda; Idah Mtete; Mercy Butia; Atupele Mpasa; Stella Wachepa; Paula Fox; Peter Wasswa; Peter Kazembe; Nader K El-Mallawany; Satish Gopal Journal: Support Care Cancer Date: 2017-10-07 Impact factor: 3.603
Authors: Paola Friedrich; Catherine G Lam; Elena Itriago; Rafael Perez; Raul C Ribeiro; Ramandeep S Arora Journal: PLoS One Date: 2015-09-30 Impact factor: 3.240